Search Results - "Kraus, Joerg"

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis by Harrer, Andrea, Pilz, Georg, Einhaeupl, Max, Oppermann, Katrin, Hitzl, Wolfgang, Wipfler, Peter, Sellner, Johann, Golaszewski, Stefan, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Kraus, Joerg

“…Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) and interferes with immune cell…”
Get full text

Laboratory biomarkers of Multiple Sclerosis (MS) by Arneth, Borros, Kraus, Jörg

“…Multiple Sclerosis (MS) is a neurological disease that affects the central nervous system (CNS). The diagnosis of the disease is quite challenging due to its…”
Get full text

Serial flow cytometric analyses of blood and cerebrospinal fluid in natalizumab-associated progressive multifocal leukencephalopathy with an excellent outcome by Pilz, Georg, Harrer, Andrea, Wipfler, Peter, Oppermann, Katrin, Sellner, Johann, Rispens, Theo, van der Kleij, Desiree, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Trinka, Eugen, Kraus, Joerg

Get full text

Management of autonomic dysfunction in severe tetanus: the importance of deep analgosedation by Duning, Thomas, Kraus, Joerg, Nabavi, Darius Guenter, Schaebitz, Wolf-Ruediger

Get full text

Experimental laboratory biomarkers in multiple sclerosis by Arneth, Borros, Kraus, Jörg

“…Summary Background Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system; the cause of this condition remains unknown…”
Get full text

Early intensive versus escalation treatment in patients with relapsing–remitting multiple sclerosis in Austria by Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

“…Objectives To compare the effectiveness of early intensive treatment (EIT) versus escalation treatment (ESC) in a nationwide observational cohort of almost…”
Get full text

The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis by Arneth, Borros, Kraus, Jörg

“…: The positive implications of using free light chains in diagnosing multiple sclerosis have increasingly gained considerable interest in medical research and…”
Get full text

Tumefactive MS lesions under fingolimod: A case report and literature review by Pilz, Georg, Harrer, Andrea, Wipfler, Peter, Oppermann, Katrin, Sellner, Johann, Fazekas, Franz, Trinka, Eugen, Kraus, Joerg

“…OBJECTIVE:To report about a possible association between fingolimod treatment and tumefactive demyelinating lesions (TDL) as seen in a patient developing…”
Get full text

Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry by Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

“…Objectives To compare the efficacy of natalizumab (NTZ) and fingolimod (FTY) in the treatment of relapsing–remitting multiple sclerosis (MS) in sequential use…”
Get full text

Sex impacts treatment decisions in multiple sclerosis by Hegen, Harald, Berek, Klaus, Deisenhammer, Florian, Berger, Thomas, Enzinger, Christian, Guger, Michael, Kraus, Jörg, Walde, Janette, Di Pauli, Franziska

“…Background Individual disease-modifying treatment (DMT) decisions might differ between female and male people with MS (pwMS). Objective To identify sex-related…”
Get full text

Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing–remitting multiple sclerosis in Austria by Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

“…Objectives To compare in a nationwide observational cohort the effectiveness, frequency and reasons for treatment interruption of dimethylfumarate (DMF) and…”
Get full text

Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry by Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

“…Objectives To evaluate long-term effectiveness of natalizumab (NTZ) and to determine demographic, clinical, and radiological predictors regarding long-term…”
Get full text

The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors by Sellner, Johann, Kraus, Jörg, Awad, Amer, Milo, Ron, Hemmer, Bernhard, Stüve, Olaf

“…Abstract Multiple sclerosis (MS) is the most common acquired inflammatory demyelinating disorder of the central nervous system (CNS). Not unlike many…”
Get full text

Real‐life use of oral disease‐modifying treatments in Austria by Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

“…Objectives To compare the efficacy, frequencies and reasons for treatment interruption of fingolimod, dimethyl fumarate (DMF) or teriflunomide in a nationwide…”
Get full text

Oral therapies for treatment of relapsing–remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method by Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas

“…Objectives To compare the efficacies, frequencies and reasons for treatment interruption of fingolimod (FTY), dimethyl fumarate (DMF) or teriflunomide (TERI)…”
Get full text

Multiple sclerosis in the elderly: a retrospective cohort study by Zinganell, Anne, Göbel, Georg, Berek, Klaus, Hofer, Barbara, Asenbaum-Nan, Susanne, Barang, Matin, Böck, Klaus, Bsteh, Christian, Bsteh, Gabriel, Eger, Stephan, Eggers, Christian, Fertl, Elisabeth, Joldic, Damir, Khalil, Michael, Langenscheidt, Dieter, Komposch, Martina, Kornek, Barbara, Kraus, Jörg, Krendl, Reinhard, Rauschka, Helmut, Sellner, Johann, Auer, Michael, Hegen, Harald, Pauli, Franziska Di, Deisenhammer, Florian

“…Background There is a lack of knowledge of disease course, prognosis, comorbidities and potential treatments of elderly MS patients. Objective To characterize…”
Get full text

Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction by Pilz, Georg, Sakic, Irma, Wipfler, Peter, Kraus, Jörg, Haschke-Becher, Elisabeth, Hitzl, Wolfgang, Trinka, Eugen, Harrer, Andrea

“…Elevation of the chemokine CXCL13 in CSF frequently occurs during active and acute CNS inflammatory processes and presumably is associated with B cell-related…”
Get full text

Do elevated autoantibodies in patients with multiple sclerosis matter? by Dal‐Bianco, Assunta, Wenhoda, Fritz, Rommer, Paulus Stefan, Weber, Michael, Altmann, Patrick, Kraus, Jörg, Leutmezer, Fritz, Salhofer‐Polanyi, Sabine

“…Objectives The incidence and clinical impact of serum autoantibodies in patients with multiple sclerosis (MS) are controversially discussed. The aim of the…”
Get full text

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome by Huss, André M., Halbgebauer, Steffen, Öckl, Patrick, Trebst, Corinna, Spreer, Annette, Borisow, Nadja, Harrer, Andrea, Brecht, Isabel, Balint, Bettina, Stich, Oliver, Schlegel, Sabine, Retzlaff, Nele, Winkelmann, Alexander, Roesler, Romy, Lauda, Florian, Yildiz, Özlem, Voß, Elke, Muche, Rainer, Rauer, Sebastian, Bergh, Florian Then, Otto, Markus, Paul, Friedemann, Wildemann, Brigitte, Kraus, Jörg, Ruprecht, Klemens, Stangel, Martin, Buttmann, Mathias, Zettl, Uwe K., Tumani, Hayrettin

“…The majority of patients presenting with a first clinical symptom suggestive of multiple sclerosis (MS) do not fulfill the MRI criteria for dissemination in…”
Get full text

Treatment strategies for vasculitis that affects the nervous system by Broussalis, Erasmia, Trinka, Eugen, Kraus, Jörg, McCoy, Mark, Killer, Monika

“…•Vasculitis is often under-recognized.•Vasculitis includes a heterogenous group of disorders.•These diseases are notoriously difficult to diagnose because of…”
Get full text